NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
NNVC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.44%160.500.0%$1938.38m
OCGNOcugen, Inc. -12.19%9.580.0%$1034.38m
SNSSSunesis Pharmaceuticals, Inc. -3.40%10.240.7%$715.81m
BNTXBioNTech SE -1.62%168.000.0%$684.21m
NVAXNovavax, Inc. 0.45%172.5279.8%$664.29m
AMGNAmgen, Inc. 0.78%251.301.3%$659.33m
GILDGilead Sciences, Inc. 0.05%66.541.0%$461.37m
REGNRegeneron Pharmaceuticals, Inc. 3.37%498.682.7%$403.21m
ALXNAlexion Pharmaceuticals, Inc. -0.03%169.862.0%$394.22m
VRTXVertex Pharmaceuticals, Inc. -0.33%213.161.9%$329.41m
ILMNIllumina, Inc. -0.33%377.093.5%$300.53m
BIIBBiogen, Inc. 0.20%272.111.7%$249.53m
VXRTVaxart, Inc. -6.10%6.930.0%$242.28m
CRSPCRISPR Therapeutics AG -5.32%107.840.6%$157.55m
BNGOBionano Genomics, Inc. -4.15%5.310.0%$131.73m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.